pHL-EF1a-SphcCas9(D10A)-iP-A
(Plasmid
#60600)
-
PurposeExpresses D10A mutant (nickase) of human codon-optimized Cas9 (derived from Streptococcus pyogenes) and pruomycin resistance gene.
-
Depositing Lab
-
Depositing OrganizationKyoto University, Center for iPS Cell Research and Application
Located in Japan -
Citations
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 60600 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 60600-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 60600-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepHL-EF1a-GW-iP-A
-
Backbone manufacturerHotta Lab, CiRA
- Backbone size w/o insert (bp) 6923
- Total vector size (bp) 9442
-
Modifications to backboneGateway system (attR1/R2) compatible mammalian expression plasmid vector, especially optimized for the use in human iPS cells. Human EF1a promoter allows to express a gene of interest at the high-level in human pluripotent stem cells.
-
Vector typeMammalian Expression, CRISPR
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameCRISPR Cas9 D10A
-
Alt nameSphcCas9 (D10A)
-
SpeciesStreptococcus pyogenes
-
Insert Size (bp)4140
-
MutationChanged Asp 10 to Ala, Codon usage optimized for human usage
Cloning Information for Gene/Insert 1
- Cloning method Gateway Cloning
- 5′ sequencing primer attR1/L1
- 3′ sequencing primer attR2/L2
- (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namepuromycin resistance gene
-
Alt namePuroR
-
SpeciesStreptomyces alboniger
-
Insert Size (bp)600
Cloning Information for Gene/Insert 2
- Cloning method Unknown
- 5′ sequencing primer Unknown
- 3′ sequencing primer Unknown
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
DNA (Catalog # 60600-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 60600-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pHL-EF1a-SphcCas9(D10A)-iP-A was a gift from Akitsu Hotta (Addgene plasmid # 60600 ; http://n2t.net/addgene:60600 ; RRID:Addgene_60600) -
For your References section:
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9. Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H, Yamamoto T, Yamanaka S, Hotta A. Stem Cell Reports. 2014 Nov 25. pii: S2213-6711(14)00335-X. doi: 10.1016/j.stemcr.2014.10.013. 10.1016/j.stemcr.2014.10.013 PubMed 25434822